Microbion Biosciences is a Bozeman, Montana, USA, biotechnology that is developing a new class of antibiotics....
Fantastic news! We've Found the answer you've been seeking!
Question:
Transcribed Image Text:
Microbion Biosciences is a Bozeman, Montana, USA, biotechnology that is developing a new class of antibiotics. The primary market that Microbion intends to develop is the diabetic foot ulcer (DFU) market for North America. The International Diabetes Federation Atlas indicates that in 2015 there were 44 million people in North America with diabetes, and this population is expected to grow to 61 million in 2040. Microbion's studies indicate that about 10% of people with diabetes in North America develop chronic foot ulcers and would benefit from their product. Microbion believes that it will successfully have a DFU product on the market by Jan 1, 2019. The total market unit sales in 2019 is forecast to be 440,000 units, and Microbion believes that it can get 20% of that total market. Microbion forecasts that total market size will increase by 1.5% each year through at least 2040. Unfortunately, Microbion's patent protection expires on December 31, 2026, so Microbion expects to have only 7 years of patent protection for its product. Upon the expiration of the patent, generics are expected to enter the market and decrease the market price of the product such that cash flows after the patent expiration will have zero net present value. The expected product price for the Microbion DFU product is $1200, and that price is expected to hold through Microbion's patent protection period which ends at the end of 2026 (although inflation would be expected to push prices up, the market power of federal government is expected to keep prices constant). Prices will adjust downward in 2027 when generics enter the market. The total costs of goods sold of producing the product are 20% of sales, and the sales, general and administrative expenses are expected to be 30% of sales. In order to continue with this project, Microbion will need to invest $21,000,000 on January 1, 2017 for the Phases 3 study which is expected to be completed in September 2017. This investment will be depreciated on a straight line basis for 7 years (through 2025), but the first year of depreciation will not occur until 2019, which is the first year of positive revenue. In addition, Microbion will need to increase the Net Working Capital of the company in 2019 by $2,000,000. These funds WILL NOT be returned at the end of the project. The probability that Microbion will successfully complete the Phase 3 study and have its DFU product accepted for the market is 75%. You have done sufficient due diligence on the numbers that Microbion has provided and have confirmed from your own sources that they are appropriate. You have determined that the appropriate cost of capital for this project is 18%. The corporate tax rate for Microbion is 35%. You also know that a multiplier of 1.2 times last year's sales is a multiplier used for valuation in the antibiotic industry. Based on the information that you have already collected and any assumptions that you need to make, determine a valuation for Microbion as if it is January 1, 2017. Clearly explain and justify how you arrived at this valuation. Discuss the different valuation approaches that are available to you, and explain why you used the approach(es) that you used. Microbion Biosciences is a Bozeman, Montana, USA, biotechnology that is developing a new class of antibiotics. The primary market that Microbion intends to develop is the diabetic foot ulcer (DFU) market for North America. The International Diabetes Federation Atlas indicates that in 2015 there were 44 million people in North America with diabetes, and this population is expected to grow to 61 million in 2040. Microbion's studies indicate that about 10% of people with diabetes in North America develop chronic foot ulcers and would benefit from their product. Microbion believes that it will successfully have a DFU product on the market by Jan 1, 2019. The total market unit sales in 2019 is forecast to be 440,000 units, and Microbion believes that it can get 20% of that total market. Microbion forecasts that total market size will increase by 1.5% each year through at least 2040. Unfortunately, Microbion's patent protection expires on December 31, 2026, so Microbion expects to have only 7 years of patent protection for its product. Upon the expiration of the patent, generics are expected to enter the market and decrease the market price of the product such that cash flows after the patent expiration will have zero net present value. The expected product price for the Microbion DFU product is $1200, and that price is expected to hold through Microbion's patent protection period which ends at the end of 2026 (although inflation would be expected to push prices up, the market power of federal government is expected to keep prices constant). Prices will adjust downward in 2027 when generics enter the market. The total costs of goods sold of producing the product are 20% of sales, and the sales, general and administrative expenses are expected to be 30% of sales. In order to continue with this project, Microbion will need to invest $21,000,000 on January 1, 2017 for the Phases 3 study which is expected to be completed in September 2017. This investment will be depreciated on a straight line basis for 7 years (through 2025), but the first year of depreciation will not occur until 2019, which is the first year of positive revenue. In addition, Microbion will need to increase the Net Working Capital of the company in 2019 by $2,000,000. These funds WILL NOT be returned at the end of the project. The probability that Microbion will successfully complete the Phase 3 study and have its DFU product accepted for the market is 75%. You have done sufficient due diligence on the numbers that Microbion has provided and have confirmed from your own sources that they are appropriate. You have determined that the appropriate cost of capital for this project is 18%. The corporate tax rate for Microbion is 35%. You also know that a multiplier of 1.2 times last year's sales is a multiplier used for valuation in the antibiotic industry. Based on the information that you have already collected and any assumptions that you need to make, determine a valuation for Microbion as if it is January 1, 2017. Clearly explain and justify how you arrived at this valuation. Discuss the different valuation approaches that are available to you, and explain why you used the approach(es) that you used.
Expert Answer:
Answer rating: 100% (QA)
To determine the valuation for Microbion as of January 1 2017 we can use a combination of valuation approaches including the discounted cash flow DCF ... View the full answer
Related Book For
Posted Date:
Students also viewed these accounting questions
-
Managing Scope Changes Case Study Scope changes on a project can occur regardless of how well the project is planned or executed. Scope changes can be the result of something that was omitted during...
-
Read the case study "Southwest Airlines," found in Part 2 of your textbook. Review the "Guide to Case Analysis" found on pp. CA1 - CA11 of your textbook. (This guide follows the last case in the...
-
Planning is one of the most important management functions in any business. A front office managers first step in planning should involve determine the departments goals. Planning also includes...
-
On 1 June 1998, Alice bought a house in Derby for 45,000. - She occupied the house as her PPR until 1 May 2000 when she left to work in Exeter, living in rented accommodation. - She returned to the...
-
(Pension Worksheet?Missing Amounts) The accounting staff of Usher Inc. has prepared the following pension worksheet. Unfortunately, several entries in the worksheet are not decipherable. The company...
-
Fuel __________________ is an important parameter that merits the use of a warning signal when it falls outside of the normal operating range.
-
The following information from Buchanan Company's current operations is available: Required a. Prepare a multiple-step income statement. Disregard earnings per share. b. Prepare a single-step income...
-
Adjusting Entries A review of the ledger of Baylor Company at December 31, 2010, produces the following data pertaining to the preparation of annual adjusting entries. 1. Salaries Payable $0. There...
-
Suppose that the S&P 500, with a beta of 1.0, has an expected return of 16% and T-bills provide a risk-free return of 7%. a. What would be the expected return and beta of portfolios constructed from...
-
Conrad Manufacturing is preparing its master budget for the first quarter of the upcoming year. The following data pertain to Conrad Manufacturing's operations: Current assets as of December 31...
-
You work as the Head of Human Resources (HR) for a large manufacturing company headquartered in California. The company is facing challenges in sales revenues and, as a result, they are working to...
-
Compose a 400-500 word message to your audience of college students briefly teaching them about plagiarism, its consequences, and its impact on a writer's authority. Your educational message should...
-
Explain a real-life incident that happened to you or an experience you had that prompts you to write an argumentative response. Think of a time when you had a problem, issue, or argument at school,...
-
Dazzle Jewelers sells diamond necklaces for $416.00 less 6%. Starlight Jewelers offers the same necklace for $454.00 less 39%, 18%. What additional rate of discount must Dazzle offer to meet the...
-
Assume you invest $112today and$318in one year from today. If you earn a 10% annual rate of return,how much will your total investments be worth in five years from today? How many years will it take...
-
i. ii. iii. iv. Refer to the original data. The president believes that a $16,000 increase in the advertising budget would result in a 3,000 increase in monthly sales units. If the president is...
-
A is classified as adiscontinued operation, The assets of A include current assets, eg. inventory( carrying value is 2000, fair value is 1500, and non-current assets, eg. land (carrying value is...
-
(a) Given a mean free path = 0.4 nm and a mean speed vav = 1.17 105 m/s for the current flow in copper at a temperature of 300 K, calculate the classical value for the resistivity of copper. (b)...
-
On March 1, Midway Distribution Company is considering leasing a building and buying the necessary equipment to operate a public warehouse. Alternatively, the company could use the funds to invest in...
-
Using the data in Exercise 6-10, assume that during the second year of operations Master Plumbing Supply Co. had net sales of $4,200,000, wrote off $60,000 of accounts as uncollectible using the...
-
Financial information related to Joshua Tree Interiors for August and September 2010 is as follows: a. Prepare balance sheets for Joshua Tree Interiors as of August 31 and as of September 30, 2010.b....
-
Total revenue for a perfectly competitive firm equals the _________ times the _________.
-
If perfectly competitive producers are currently making economic profits, the market supply curve will shift to the right over time as more firms _________ and existing firms _________.
-
As entry into a profitable industry pushes down the market price, producers will move from a situation where price _________ average total cost to one where price _________ average total cost.
Study smarter with the SolutionInn App